A detailed history of Geneos Wealth Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 92,395 shares of BMY stock, worth $5.34 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
92,395
Previous 69,182 33.55%
Holding current value
$5.34 Million
Previous $2.87 Million 66.41%
% of portfolio
0.18%
Previous 0.13%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $920,627 - $1.2 Million
23,213 Added 33.55%
92,395 $4.78 Million
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $505,741 - $665,819
-12,565 Reduced 15.37%
69,182 $2.87 Million
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $5,133 - $5,820
107 Added 0.13%
81,747 $4.43 Million
Q4 2023

Jan 26, 2024

SELL
$48.48 - $57.85 $715,322 - $853,576
-14,755 Reduced 15.31%
81,640 $4.19 Million
Q3 2023

Oct 11, 2023

BUY
$57.89 - $64.73 $379,874 - $424,758
6,562 Added 7.3%
96,395 $5.59 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $751,204 - $834,095
11,791 Added 15.11%
89,833 $5.74 Million
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $580,613 - $658,547
-8,836 Reduced 10.17%
78,042 $5.41 Million
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $1.19 Million - $1.41 Million
17,357 Added 24.97%
86,878 $6.25 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $1,475 - $872,134
-11,350 Reduced 14.03%
69,521 $4.94 Million
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $580,233 - $639,040
-7,990 Reduced 8.99%
80,871 $6.23 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $416,158 - $499,010
-6,769 Reduced 7.08%
88,861 $6.49 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $692,738 - $807,570
-12,917 Reduced 11.9%
95,630 $5.97 Million
Q3 2021

Nov 09, 2021

SELL
$59.17 - $69.31 $172,658 - $202,246
-2,918 Reduced 2.62%
108,547 $6.46 Million
Q2 2021

Jul 08, 2021

SELL
$61.91 - $67.42 $620,090 - $675,278
-10,016 Reduced 8.24%
111,465 $7.46 Million
Q1 2021

Jun 17, 2021

BUY
$59.34 - $66.74 $90,849 - $102,178
1,531 Added 1.28%
121,481 $7.59 Million
Q4 2020

May 19, 2021

BUY
$57.74 - $65.43 $476,874 - $540,386
8,259 Added 7.39%
119,950 $7.27 Million
Q3 2020

Sep 07, 2021

SELL
$57.43 - $63.64 $1.13 Million - $1.25 Million
-19,692 Reduced 14.99%
111,691 $6.65 Million
Q2 2020

Sep 07, 2021

BUY
$54.82 - $64.09 $84,861 - $99,211
1,548 Added 1.19%
131,383 $7.56 Million
Q1 2020

Sep 07, 2021

BUY
$46.4 - $67.43 $4.56 Million - $6.63 Million
98,276 Added 311.4%
129,835 $6.86 Million
Q4 2019

Sep 07, 2021

SELL
$49.21 - $64.19 $247,280 - $322,554
-5,025 Reduced 13.74%
31,559 $2.02 Million
Q3 2019

Sep 07, 2021

BUY
$42.77 - $50.71 $160,986 - $190,872
3,764 Added 11.47%
36,584 $1.84 Million
Q2 2019

Sep 07, 2021

BUY
$44.62 - $49.34 $291,502 - $322,338
6,533 Added 24.85%
32,820 $1.49 Million
Q1 2019

Sep 07, 2021

SELL
$45.12 - $53.8 $37,539 - $44,761
-832 Reduced 3.07%
26,287 $1.25 Million
Q4 2018

Sep 07, 2021

SELL
$48.76 - $63.23 $31,889 - $41,352
-654 Reduced 2.35%
27,119 $1.38 Million
Q3 2018

Sep 07, 2021

SELL
$55.19 - $62.25 $2,483 - $2,801
-45 Reduced 0.16%
27,773 $1.72 Million
Q2 2018

Sep 07, 2021

SELL
$50.53 - $62.98 $57,755 - $71,986
-1,143 Reduced 3.95%
27,818 $1.54 Million
Q1 2018

Sep 07, 2021

SELL
$59.92 - $68.98 $71,244 - $82,017
-1,189 Reduced 3.94%
28,961 $1.83 Million
Q4 2017

Sep 07, 2021

SELL
$59.94 - $65.35 $31,588 - $34,439
-527 Reduced 1.72%
30,150 $1.85 Million
Q3 2017

Sep 07, 2021

SELL
$55.23 - $63.74 $61,802 - $71,325
-1,119 Reduced 3.52%
30,677 $1.96 Million
Q2 2017

Sep 07, 2021

BUY
N/A
1,410 Added 4.64%
31,796 $1.77 Million
Q1 2017

Sep 07, 2021

BUY
N/A
22 Added 0.07%
30,386 $1.65 Million
Q4 2016

Sep 07, 2021

SELL
N/A
-8,170 Reduced 21.2%
30,364 $1.77 Million
Q3 2016

Sep 07, 2021

BUY
N/A
4,246 Added 12.38%
38,534 $2.08 Million
Q2 2016

Sep 07, 2021

SELL
N/A
-981 Reduced 2.78%
34,288 $2.53 Million
Q1 2016

Sep 07, 2021

BUY
N/A
35,269
35,269 $2.29 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.